New Market Report Now Available: Treatment Algorithms: Osteoporosis - A Condition Plagued By Low Diagnosis And Treatment Rates, Low Compliance, And The Side Effects Of The Key Bisphosphonate Class

New Pharmaceuticals research report from Datamonitor is now available from Fast Market Research

by Bill Thompson

(WireNews+Co) - Boston, MA - 26 October 2012

According to the World Health Organization (WHO), osteoporosis is defined as a systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to fracture.

Scope
- Datamonitor's comprehensive treatment algorithms includes latest primary research showing physician-reported presentation and diagnosis rates.
- Gain insight into the most commonly used treatments across osteoporosis subgroups and find out how prescription habits differ between countries.
- Understand factors influencing prescribing habits in each market and read about unmet clinical needs.

Highlights

With an increasingly aging population, bone loss and associated fragility fractures become progressively more important for healthcare providers and society; bone loss as the cause of fragility fractures is a modifiable risk. The market for anti-osteoporotic drugs is therefore growing and becoming more attractive.

View Full Report Details and Table of Contents (http://www.fastmr.com/prod/464853_treatment_algorithms_osteoporosis_a_condition.aspx) (http://www.fastmr.com/prod/464853_treatment_algorithms_osteoporosis_a_condition.aspx)

Disease awareness is relatively low and may negatively affect presentation rates. Improving awareness could achieve increased presentation and therefore diagnosis rates, a way of growing the market faster.

Diagnoses are mostly based on primary assessment from general practitioners, combined with the use of additional diagnostic techniques such as bone densitometry. Referrals to specialists occur in less than a third of cases for patients in first-line therapy.

Reasons to Get this Report
- What are the presentation and diagnosis rates in osteoporosis for each of the seven major markets?
- Which drugs are most commonly prescribed for each of the three osteoporosis severities and what factors influence physician prescribing decisions?
- What usually causes therapy changes and to what extent do osteoporosis patients get referred on to specialists?
- What are the highest priority needs in the osteoporosis market?

Fast Market Research (http://www.fastmr.com) is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.